GAZYVA J Code: J9301

Drug & Product Overview

HCPCS Descriptor Injection, obinutuzumab, 10 mg

HCPCS Added Date January 1, 2015

Manufacturer Genentech

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution, Concentrate

About GAZYVA

Gazyva is a medication aligned to the HCPCS J Code: J9301 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Genentech.

According to CMS Drug Use Information: Obinutuzumab is used to treat certain types of blood cancer (such as chronic lymphocytic leukemia, follicular lymphoma). This medication is also used to treat a certain kidney disorder (lupus nephritis). Lupus nephritis is an immune disorder where certain proteins in your own body attack and cause damage to the kidneys. Obinutuzumab belongs to a class of drugs known as monoclonal antibodies. It works by stopping the growth of cancer cells. In lupus nephritis, obinutuzumab works by decreasing damage to the kidneys.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50242-0070-01	Gazyva	Genentech, Inc.	100	1000 MG / 40 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

GAZYVA Pricing & Reimbursement

J9301 Private Payer Reimbursement

$83.87 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

GAZYVA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 12.04%

Avg. Days to File 7.2days

Avg. Days to Pay 23.1days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9301 claims analytics on FocalPoint →

GAZYVA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Gazyva (J9301) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

GAZYVA Medically Unlikely Edits (MUE)

The most billing units of J9301 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

100 units / day

= 1,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

GAZYVA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chronic Lymphocytic Leukemia Follicular Lymphoma Lupus Nephritis

Drug Class

CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]

Frequently Asked Questions

Is there an available Gazyva billing and coding guide?

Billing and coding information for GAZYVA can be found through Genentech. Visit Here →

Are there any available Gazyva patient assistance programs?

GAZYVA patient assistance information can be found through Genentech. Visit Here →

Where can I find Gazyva prescribing information?

GAZYVA prescribing information can be found at the link below: Visit Here →

Where can I find Gazyva side effect information?

Information regarding GAZYVA's side effects can be found at MedlinePlus Visit Here →

Does billing GAZYVA require JZ/JW wastage modifiers?

CMS has identified GAZYVA(J9301) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.